Trial · NCT03158220
Results by group46
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 46
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 16-26 Years of Age | Anti-HPV 6 | 787.8 | 95% Confidence Interval 732.5 to 847.2 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 27-45 Years of Age | Anti-HPV 6 | 638.4 | 95% Confidence Interval 594.9 to 685.0 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 16-26 Years of Age | Anti-HPV 11 | 598.7 | 95% Confidence Interval 558.7 to 641.6 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 27-45 Years of Age | Anti-HPV 11 | 453.5 | 95% Confidence Interval 424.1 to 485.0 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 16-26 Years of Age | Anti-HPV 16 | 3075.8 | 95% Confidence Interval 2863.4 to 3303.9 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 27-45 Years of Age | Anti-HPV 16 | 2147.5 | 95% Confidence Interval 2001.1 to 2304.5 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 16-26 Years of Age | Anti-HPV 18 | 744.5 | 95% Confidence Interval 685.0 to 809.1 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 27-45 Years of Age | Anti-HPV 18 | 532.1 | 95% Confidence Interval 491.8 to 575.7 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 16-26 Years of Age | Anti-HPV 31 | 596.1 | 95% Confidence Interval 551.1 to 644.9 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 27-45 Years of Age | Anti-HPV 31 | 395.7 | 95% Confidence Interval 367.0 to 426.6 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 16-26 Years of Age | Anti-HPV 33 | 354.5 | 95% Confidence Interval 331.7 to 378.9 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 27-45 Years of Age | Anti-HPV 33 | 259.0 | 95% Confidence Interval 242.9 to 276.1 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 16-26 Years of Age | Anti-HPV 45 | 214.9 | 95% Confidence Interval 197.7 to 233.7 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 27-45 Years of Age | Anti-HPV 45 | 145.6 | 95% Confidence Interval 134.4 to 157.7 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 16-26 Years of Age | Anti-HPV 52 | 346.5 | 95% Confidence Interval 324.0 to 370.5 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 27-45 Years of Age | Anti-HPV 52 | 244.7 | 95% Confidence Interval 229.4 to 261.0 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 16-26 Years of Age | Anti-HPV 58 | 428.0 | 95% Confidence Interval 399.4 to 458.6 | mMU/mL |
| Anti-HPV Geometric Mean Titers (GMTs) for Each Anti-HPV Type | Women 27-45 Years of Age | Anti-HPV 58 | 296.4 | 95% Confidence Interval 277.1 to 317.0 | mMU/mL |
| Percentage of Participants That Experienced at Least 1 Adverse Event (AE) | Women 16-26 Years of Age | 92.8 | Percentage of Participants | ||
| Percentage of Participants That Experienced at Least 1 Adverse Event (AE) | Women 27-45 Years of Age | 92.5 | Percentage of Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03158220/results